Speeding To Success: Accelerating Cell Therapy Development And Manufacturing Workflows

Many cell therapy developers are held back by outdated and inefficient processes that can't meet the demands of today's rapidly innovating market. These legacy systems often lack the automation, flexibility, and scalability required to meet increasingly stringent regulatory requirements, leading to potential delays and inconsistencies. To truly accelerate workflows, next-generation solutions are needed.
Advanced, automated systems can significantly reduce processing times—for instance, cutting bead removal from five hours to under one hour—while lowering the risk of contamination and human error. Furthermore, modular instrumentation enables a seamless transition from development to commercial production, helping to avoid costly delays.
Access the article to learn how a trusted supplier can help you overcome limitations and enhance therapeutic efficacy.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.